Live Cell Encapsulation - The Bioengineering Breakthrough Revolutionizing Therapeutics with Controlled Drug Delivery - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Live Cell Encapsulation Market - Global Industry Forecast to 2028" report has been added to ResearchAndMarkets.com's offering.

With an expected robust CAGR in the forecast period of 2024-2028, this revolutionary technology showcases promising growth prospects. Factors such as increased research & development efforts to enhance cell encapsulation technologies and a surge in government and private investments supporting live cell encapsulated product development contribute to this market's promising trajectory.

Revolutionizing Therapeutics:

Live cell encapsulation, a cutting-edge bioengineering technology, entails encasing living cells with specialized materials or coatings. This innovative approach utilizes various materials like liposomes, hydrogels, and microcapsules for encapsulation.

A Catalyst for Cell Therapies:

Live cell encapsulation plays a pivotal role in cell therapies, enabling controlled release of bioactive materials or cells, thus bolstering the market growth amid a rising demand for cell therapies worldwide. Its unique feature of avoiding immune system response ensures encapsulated cells can carry out specific functions effectively, such as activating cancer drugs. In a groundbreaking research study in 2021, Nuvilex utilized encapsulated live cells to treat pancreatic cancer, successfully converting inactive cancer drugs into their cancer-killing form, delivering targeted and potent chemotherapeutic treatment directly to tumors.

Tackling Chronic Diseases:

The prevalence of chronic diseases like cancer and diabetes has surged globally, posing significant health challenges. Live cell encapsulation holds immense promise in the treatment of chronic diseases, including type 1 diabetes, cancer, and autoimmune disorders. The technology's application in delivering insulin-producing cells and dopamine delivery for Parkinson's disease has garnered attention, propelling the market forward. With the number of chronic disease cases on the rise, companies are incorporating and refining live cell encapsulation to meet the growing demand.

Research and Development Pave the Way:

The ever-expanding biotechnology sector, driven by extensive research & development and increased investments from key market players, contributes to the remarkable clinical efficacy and development of live cell encapsulation. Notable partnerships and collaborations, like BIO INX and Nanoscribe's HYDROBIO INX N400, offering 3D printing-enabled cell encapsulation, underscore the potential of live cell encapsulation. In July 2021, PharmaCyte Biotech embarked on a two-phase pig study to investigate live-cell encapsulation technology for diabetes treatment, further fueling research opportunities.

Market Segmentation and Competitive Landscape:

The Global Live Cell Encapsulation Market is segmented based on polymer type, application, technique, region, and competitive landscape. Polymer types include alginate, chitosan, cellulose sulfate, and others. Applications span drug delivery, regenerative medicine, cell transplantation, and probiotics. Techniques encompass simple dripping, electrostatic dripping, and coaxial airflow. The report further analyzes market dynamics, trends, developments, and competitive landscapes with profiles of key players like AUSTRIANOVA, Merck KGaA, Sphere Fluidics Ltd., ViaCyte, Inc., and more.

Competitive Landscape

Detailed analysis of the major companies present in the Global Live Cell Encapsulation Market include:

• AUSTRIANOVA
• Merck KGaA
• Sphere Fluidics Ltd.
• ViaCyte, Inc.
• Blacktrace Holdings Ltd. (Dolomite Microfluidics)
• BIO INX
• Living Cell Technologies Ltd.
• Sigilon Therapeutics, Inc.
• Isogen
• Diatranz Otsuka Ltd.

For more information about this report visit https://www.researchandmarkets.com/r/dep88h

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900